This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Incidence

Authoring team

The condition is most common in teenagers with about 60% affected sufficiently to seek treatment:

  • 85% of people between the ages of 12 and 24 years have acne, and while it is most common in teenagers, acne affects 8% of adults aged 25-34 years, and 3% of adults aged 35-44 years. (1
  • peak incidence is seen in females aged 14-17 years and in males aged 16-19 years (1)
  • is most prevalent among young people and younger adults, affecting approximately 80% of people at some time between 11 and 30 years (2)
  • boys and men tend to get acne more severely than girls and women (3)
  • about 5% of women and 1% of men aged 25-40 years either continues to get acne lesions or they may develop late-onset acne (1)
    • prevalence in this age group is believed to be increasing

Presentation in infancy occurs rarely.

References:

1. Karimkhani C et al. Global skin disease morbidity and mortality: an update from the Global Burden of Disease Study 2013. JAMA Dermatol. 2017 May 1;153(5):406-12.

2. NICE (May 2023). Acne vulgaris: management

3. Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015 Jul;172(1):3-12.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.